Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinoma
about
Genomic profiling of genes contributing to metastasis in a mouse model of thyroid follicular carcinoma.Cross-talk between PI3K and estrogen in the mouse thyroid predisposes to the development of follicular carcinomas with a higher incidence in females.Molecular pathogenesis and mechanisms of thyroid cancerSynergistic signaling of KRAS and thyroid hormone receptor β mutants promotes undifferentiated thyroid cancer through MYC up-regulation.Thyroid hormone receptor beta (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC)Oncogenic Actions of the Nuclear Receptor Corepressor (NCOR1) in a Mouse Model of Thyroid Cancer.Global expression profiling reveals gain-of-function oncogenic activity of a mutated thyroid hormone receptor in thyroid carcinogenesis.Extranuclear signaling of mutated thyroid hormone receptors in promoting metastatic spread in thyroid carcinogenesisAkt1 deficiency delays tumor progression, vascular invasion, and distant metastasis in a murine model of thyroid cancerOncogenic mutations of thyroid hormone receptor β.SKI-606, an Src inhibitor, reduces tumor growth, invasion, and distant metastasis in a mouse model of thyroid cancerModeling follicular thyroid cancer for future therapiesMouse models of follicular and papillary thyroid cancer progression.Thyroid hormone receptors and cancer.MicroRNAs in thyroid cancer.Thyroid hormone receptor β suppresses SV40-mediated tumorigenesis via novel nongenomic actionsRole of TSH in the spontaneous development of asymmetrical thyroid carcinoma in mice with a targeted mutation in a single allele of the thyroid hormone-β receptorDiet-induced obesity increases tumor growth and promotes anaplastic change in thyroid cancer in a mouse modelActivation of tumor cell proliferation by thyroid hormone in a mouse model of follicular thyroid carcinoma.Complex temporal changes in TGFβ oncogenic signaling drive thyroid carcinogenesis in a mouse modelObatoclax kills anaplastic thyroid cancer cells by inducing lysosome neutralization and necrosisThyrotropin signaling confers more aggressive features with higher genomic instability on BRAF(V600E)-induced thyroid tumors in a mouse modelElevated HMGN4 expression potentiates thyroid tumorigenesis.Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor β.Thyroid Stimulating Hormone ReceptorRAP1GAP inhibits cytoskeletal remodeling and motility in thyroid cancer cells.Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumorsIn vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis.Higher TSH level is a risk factor for differentiated thyroid cancer.BRAF-Oncogene-Induced Senescence and the Role of Thyroid-Stimulating Hormone Signaling in the Progression of Papillary Thyroid Carcinoma.Downregulated expression of TSHR is associated with distant metastasis in thyroid cancer.Interplay between TRα1 and Wnt signaling: A dangerous liaison
P2860
Q33895984-2207F9C3-0568-4A64-91A0-4D8A576EBF9EQ34259396-04A9D7A4-0D0D-4AC6-87D2-CF6D370D4E17Q34329018-1764ED99-42C8-434B-9D6C-DD446DFA5CACQ34528284-E14A072A-6082-4C71-B7C6-A10921F3359AQ34617075-11666BC7-F5E6-4C3C-B07F-F417BA27409BQ34808224-0E627A14-C36C-42E5-9512-0244DD718226Q34914923-269E6F9E-D66B-494E-9EBD-EDD15DD03302Q35085667-3A72B582-33A1-46DF-A730-0EF0633CDE54Q35151491-6878DCC5-65CC-467A-A0CB-1ADB9600E832Q35781521-8C9EC86D-65D7-4D98-896B-D17755AE25EEQ35803670-19F9DDC5-60A1-4738-95CC-C68FB4CE089CQ35832908-C7809DEE-5E7C-4C56-AFEA-BEC9A86CF68AQ35971896-33C4242E-5AB1-4D4E-9B46-B9483487C5BCQ36120590-9F9B83E3-34D0-4BB0-B21A-B6EFF61CAAE9Q36134682-59195A0C-127C-4223-90E8-2E92BE92AD2EQ36206509-B3A6E20A-7183-4ECD-82E2-26F193A7228FQ36439404-166B99FA-9588-461F-A059-0F2C93C7610AQ37018515-FCF7E498-196C-442B-9B00-2E47D1451737Q37058438-CABAC910-8B4A-4E6F-9F94-2BE099409017Q37205853-05EC6A83-EDCA-424B-86CE-38F57532F40FQ37376300-777FA802-57CB-428C-A488-9C83935726E2Q37630088-44D4BE5B-E6C2-4E20-BC52-3DA4CA46B867Q38716948-55F3E2E0-0E73-4D5F-88C6-C298C00C5FFBQ38766990-94D152BD-BBE7-4A8C-97D3-B7892BAE5772Q39100649-0886E371-61EB-4856-89B0-16D7E4B004E0Q39331598-D80A094D-EB74-4083-967B-D9CD71EF605AQ39424181-5F501D13-EBD7-4B97-8A20-09807B1427F3Q46054824-3E69E62B-3AC4-43E3-8A7E-1764DEFF3C29Q46929617-C6FA7576-9C28-4EBD-A448-A46BD3F16129Q47325187-29AEE0BE-7015-457D-AC38-D88CB47AC71BQ49364377-08BA57BF-4CF8-46E9-8583-3970B2469DE1Q58789597-A8682CB1-8F54-4A23-9D76-815682466B6E
P2860
Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinoma
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Growth activation alone is not ...... f follicular thyroid carcinoma
@ast
Growth activation alone is not ...... f follicular thyroid carcinoma
@en
type
label
Growth activation alone is not ...... f follicular thyroid carcinoma
@ast
Growth activation alone is not ...... f follicular thyroid carcinoma
@en
prefLabel
Growth activation alone is not ...... f follicular thyroid carcinoma
@ast
Growth activation alone is not ...... f follicular thyroid carcinoma
@en
P2093
P2860
P356
P1433
P1476
Growth activation alone is not ...... f follicular thyroid carcinoma
@en
P2093
Changxue Lu
Mark C Willingham
Sheue-Yann Cheng
P2860
P304
P356
10.1210/EN.2009-1017
P407
P577
2010-02-04T00:00:00Z